Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 1 hr 48 mins

S&P Futures
5,887.00
-19.00(-0.32%)
Dow Futures
43,427.00
-91.00(-0.21%)
Nasdaq Futures
20,360.75
-122.75(-0.60%)
Russell 2000 Futures
2,283.80
-7.40(-0.32%)
Crude Oil
70.72
+1.50(+2.17%)
Gold
2,751.90
+21.90(+0.80%)

Aptose Biosciences Inc. (APS.TO)

Toronto - Toronto Real Time Price. Currency in CAD

Follow

0.5500

+0.0500

(+10.00%)

At close: 02:00PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	9.96M
Enterprise Value	-404.07k
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	68.22
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	0.07

Trading Information

Stock Price History

Beta (5Y Monthly)	1.36
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	4.5600
52 Week Low ³	0.4600
50-Day Moving Average ³	0.5438
200-Day Moving Average ³	1.4991

Share Statistics

Avg Vol (3 month) ³	7.21k
Avg Vol (10 day) ³	5.88k
Shares Outstanding ⁵	18.11M
Implied Shares Outstanding ⁶	N/A
Float ⁸	13.3M
% Held by Insiders ¹	17.11%
% Held by Institutions ¹	15.08%
Shares Short (Sep 30, 2024) ⁴	14.33k
Short Ratio (Sep 30, 2024) ⁴	1.72
Short % of Float (Sep 30, 2024) ⁴	0.10%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	0.08%
Shares Short (prior month Aug 30, 2024) ⁴	16.95k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:12
Last Split Date ³	Oct 06, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-136.29%
Return on Equity (ttm)	-694.13%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-40.85M
Net Income Avi to Common (ttm)	-40.29M
Diluted EPS (ttm)	-5.8300
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	8.33M
Total Cash Per Share (mrq)	0.46
Total Debt (mrq)	818k
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.80
Book Value Per Share (mrq)	-0.12

Cash Flow Statement

Operating Cash Flow (ttm)	-37.34M
Levered Free Cash Flow (ttm)	-22.32M